⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3813678 | 0.74 | — | — | |
| SCHEMBL20468898 | 0.74 | — | — | |
| SCHEMBL17652543 | 0.74 | — | — | |
| SCHEMBL25165048 | 0.65 | — | — | |
| SCHEMBL6982703 | 0.65 | — | — | |
| SCHEMBL13369627 | 0.65 | — | — | |
| SCHEMBL2841282 | 0.65 | — | — | |
| SCHEMBL18892488 | 0.65 | — | — | |
| Azetidine SCHEMBL29267871 | 0.61 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL25646629 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010049678-A2 | TREATMENT OF ENERGY UTILIZATION DISEASES | SUMMIT CORPORATION PLC (GB) | 2010-05-06 | — | — | WO | disclosed |